Controversial Trade Agreement Could Make "Bio-Piracy" Worse

The Citizen's Guide to the Future
Dec. 6 2013 1:47 PM

TPP Trade Agreement Could Make "Bio-Piracy" Worse

73969986
A hoodia gordonii succulent

Photo by David Silverman/Getty Images

This blog post is part of Future Tense, a collaboration among Arizona State University, the New America Foundation, and Slate that explores the ways emerging technologies affect society, policy, and culture. On Dec. 9, 2013, Future Tense will host an event on patent reform in Washington, D.C. For more information and to RSVP, visit the New America website.

The West’s infatuation with organic foods and natural ingredients can be found in pharmaceutical and agricultural companies, too. Just as they have since our earliest days, researchers today look to the botanic for the cure to what ails us. (Of course, “natural” and “organic” are somewhat fuzzy labels. Just this year, Naked Juices settled a class action suit for $9 million after their “all natural” juices were found to contain cyanocobalamin, Fibersol®-2, and pyridoxine hydrochloride.) Once a new miracle plant has been found, companies can process and profit. According to a 2012 European Union report, 26 percent of all new approved drugs over the last 30 years are either natural products or have been derived from a natural material, and that number is set to grow. Just think about the ascendency of the acai berry.

Advertisement

But the commercialization of genetic resources found in biologically diverse areas like the Amazon and India comes with a cost. In a practice sometimes called bio-piracy, companies use patents to secure lucrative monopolies on plants, genes, and traditional knowledge in developing countries, often without cutting native people in on the profits. And the United States is apparently attempting to make this practice even easier for American companies.

Bio-piracy was a key grievance of the anti-globalization movement of the 1990s and early 2000s. Activists still call it a form of “colonial pillaging,” particularly because accusations of bio-piracy are most frequently levied against European and American companies scouring the developing world for the next big thing.

The Neem case was one such flashpoint. Foreign companies attempted to patent the use of the kernels of the Neem tree as a nonchemical pesticide, despite it having been used by Indian famers for that purpose for decades. Likewise, the British company Phytopharm claimed in the early 2000s to have discovered that Africa’s Hoodia was a miracle diet drug and very profitably sold it to U.S. pharmaceutical giant Pfizer. As it turned out, the Kung bushmen of southern Africa traditionally used the cactus as an appetite-suppressant on hunting trips, although Phytopharm neglected to compensate them for their knowledge. Phytopharm’s CEO even (incorrectly) told the Financial Times that fair repayment was impossible as the tribe was extinct.

Equity is not the only thing at stake. If a company is able to patent and popularize the medical use of a particular plant, its harvesting often becomes environmentally unsustainable, which can make it impossible for locals to use the plant for their traditional—often medicinal—purposes.

Though it rarely gets as much attention as other environmental issues, bio-piracy has been the focus of a number of international treaties, resulting in a growing array of protections that allow countries to benefit from and protect their native resources and ancient knowledge. Their rights have even been written into the 2007 U.N. Declaration on the Rights of Indigenous Peoples, which now states that “Indigenous peoples have the right to maintain, control, protect and develop … the manifestations of their sciences, technologies and cultures, including human and genetic resources, seeds, medicines, knowledge of the properties of fauna and flora.” Yet even as the European Union is exploring an agreement that would force companies to repay locals in the regions they exploit—based on the so-called Nagoya Protocol—the United States is running in the other direction and trying to take everyone along. 

The secret Trans-Pacific Partnership negotiation documents recently published by WikiLeaks show that the United States wants to give companies even more legal cover to patent the resources of other countries. The draft language would "make patents available for inventions for the following: plants and animals" and also allow “diagnostic, therapeutic, and surgical methods for the treatment of humans or animals" to be patented. The language is opposed by a number of countries that intend to eventually ratify TPP, including New Zealand, but the language could still make it into the final treaty—and if it does, it could undermine global efforts to provide proper recompense to developing nations for the use of their natural assets.

So the next time you hear about a new miracle plant that promises to make you instantly thin, remember: Not only have many of these natural cures failed to live up to the hype—but they may also be exploiting native populations without fair compensation.

Future Tense is a partnership of SlateNew America, and Arizona State University.

TODAY IN SLATE

Politics

Talking White

Black people’s disdain for “proper English” and academic achievement is a myth.

Hong Kong’s Protesters Are Ridiculously Polite. That’s What Scares Beijing So Much.

The One Fact About Ebola That Should Calm You: It Spreads Slowly

Operation Backbone

How White Boy Rick, a legendary Detroit cocaine dealer, helped the FBI uncover brazen police corruption.

A Jaw-Dropping Political Ad Aimed at Young Women, Apparently

The XX Factor
Oct. 1 2014 4:05 PM Today in GOP Outreach to Women: You Broads Like Wedding Dresses, Right?
Music

How Even an Old Hipster Can Age Gracefully

On their new albums, Leonard Cohen, Robert Plant, and Loudon Wainwright III show three ways.

How Tattoo Parlors Became the Barber Shops of Hipster Neighborhoods

This Gargantuan Wind Farm in Wyoming Would Be the Hoover Dam of the 21st Century

Moneybox
Oct. 1 2014 8:34 AM This Gargantuan Wind Farm in Wyoming Would Be the Hoover Dam of the 21st Century To undertake a massively ambitious energy project, you don’t need the government anymore.
  News & Politics
Politics
Oct. 1 2014 7:26 PM Talking White Black people’s disdain for “proper English” and academic achievement is a myth.
  Business
Buy a Small Business
Oct. 1 2014 11:48 PM Inking the Deal Why tattoo parlors are a great small-business bet.
  Life
Outward
Oct. 1 2014 6:02 PM Facebook Relaxes Its “Real Name” Policy; Drag Queens Celebrate
  Double X
The XX Factor
Oct. 1 2014 5:11 PM Celebrity Feminist Identification Has Reached Peak Meaninglessness
  Slate Plus
Behind the Scenes
Oct. 1 2014 3:24 PM Revelry (and Business) at Mohonk Photos and highlights from Slate’s annual retreat.
  Arts
Brow Beat
Oct. 1 2014 9:39 PM Tom Cruise Dies Over and Over Again in This Edge of Tomorrow Supercut
  Technology
Future Tense
Oct. 1 2014 6:59 PM EU’s Next Digital Commissioner Thinks Keeping Nude Celeb Photos in the Cloud Is “Stupid”
  Health & Science
Science
Oct. 1 2014 4:03 PM Does the Earth Really Have a “Hum”? Yes, but probably not the one you’re thinking.
  Sports
Sports Nut
Oct. 1 2014 5:19 PM Bunt-a-Palooza! How bad was the Kansas City Royals’ bunt-all-the-time strategy in the American League wild-card game?